Hiroyoshi Isoda
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Development of a Deep Learning Model for Automated Measurement of Skeletal Muscle Volume in 18F-FDG PET/CT.
Journal: Journal of imaging informatics in medicine
Published: April 19, 2026
Proposing oligo-recurrence criteria in pancreatic ductal adenocarcinoma: A stratified analysis of locoregional treatment benefits.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: March 12, 2025
Neoadjuvant chemoradiotherapy using moderately hypofractionated intensity-modulated radiotherapy for borderline resectable pancreatic cancer : Outcomes and prognostic radiotherapeutic factors.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: November 30, 2024
Neoadjuvant Chemoradiotherapy Using Moderately Hypofractionated Intensity-Modulated Radiotherapy Versus Upfront Surgery for Resectable Pancreatic Cancer: A Retrospective Cohort Study.
Journal: Annals of surgical oncology
Published: October 05, 2024
Outcomes and Role of Lymphadenectomy in Hypervascular Intrahepatic Cholangiocarcinoma Based on CT-Vascularity.
Journal: World journal of surgery
Published: July 04, 2024
In Vivo and Post-mortem Comparisons of IVIM/Time-dependent Diffusion MR Imaging Parameters in Melanoma and Breast Cancer Xenograft Models.
Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
Published: May 26, 2024
The effect of hormone therapy on physiological uptake of the endometrium on [18F]F-FDG PET in postmenopausal women.
Journal: Annals of nuclear medicine
Published: April 10, 2024
Association Between Pancreatic Cysts and Diabetes Mellitus in Von Hippel-Lindau Disease.
Journal: Cureus
Published: February 20, 2024
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study.
Journal: Cancer medicine
Published: April 06, 2023
Last Updated: 09/26/2026